Hepatitis B virus genotypes: global distribution and clinical importance

At least 600000 individuals worldwide annually die of hepatitis B virus (HBV)-related diseases, such as chronic hepatitis B (CHB), liver cirrhosis (LC), and hepatocellular carcinoma (HCC). Many viral factors, such as viral load, genotype, and specific viral mutations, are known to affect disease pro...

Celý popis

Uložené v:
Podrobná bibliografia
Vydané v:World journal of gastroenterology : WJG Ročník 20; číslo 18; s. 5427
Hlavný autor: Sunbul, Mustafa
Médium: Journal Article
Jazyk:English
Vydavateľské údaje: United States 14.05.2014
Predmet:
ISSN:2219-2840, 2219-2840
On-line prístup:Zistit podrobnosti o prístupe
Tagy: Pridať tag
Žiadne tagy, Buďte prvý, kto otaguje tento záznam!
Abstract At least 600000 individuals worldwide annually die of hepatitis B virus (HBV)-related diseases, such as chronic hepatitis B (CHB), liver cirrhosis (LC), and hepatocellular carcinoma (HCC). Many viral factors, such as viral load, genotype, and specific viral mutations, are known to affect disease progression. HBV reverse transcriptase does not have a proofreading function, therefore, many HBV genotypes, sub-genotypes, mutants, and recombinants emerge. Differences between genotypes in response to antiviral treatment have been determined. To date, 10 HBV genotypes, scattered across different geographical regions, have been identified. For example, genotype A has a tendency for chronicity, whereas viral mutations are frequently encountered in genotype C. Both chronicity and mutation frequency are common in genotype D. LC and progression to HCC are more commonly encountered with genotypes C and D than the other genotypes. Pathogenic differences between HBV genotypes explain disease intensity, progression to LC, and HCC. In conclusion, genotype determination in CHB infection is important in estimating disease progression and planning optimal antiviral treatment.
AbstractList At least 600000 individuals worldwide annually die of hepatitis B virus (HBV)-related diseases, such as chronic hepatitis B (CHB), liver cirrhosis (LC), and hepatocellular carcinoma (HCC). Many viral factors, such as viral load, genotype, and specific viral mutations, are known to affect disease progression. HBV reverse transcriptase does not have a proofreading function, therefore, many HBV genotypes, sub-genotypes, mutants, and recombinants emerge. Differences between genotypes in response to antiviral treatment have been determined. To date, 10 HBV genotypes, scattered across different geographical regions, have been identified. For example, genotype A has a tendency for chronicity, whereas viral mutations are frequently encountered in genotype C. Both chronicity and mutation frequency are common in genotype D. LC and progression to HCC are more commonly encountered with genotypes C and D than the other genotypes. Pathogenic differences between HBV genotypes explain disease intensity, progression to LC, and HCC. In conclusion, genotype determination in CHB infection is important in estimating disease progression and planning optimal antiviral treatment.
At least 600000 individuals worldwide annually die of hepatitis B virus (HBV)-related diseases, such as chronic hepatitis B (CHB), liver cirrhosis (LC), and hepatocellular carcinoma (HCC). Many viral factors, such as viral load, genotype, and specific viral mutations, are known to affect disease progression. HBV reverse transcriptase does not have a proofreading function, therefore, many HBV genotypes, sub-genotypes, mutants, and recombinants emerge. Differences between genotypes in response to antiviral treatment have been determined. To date, 10 HBV genotypes, scattered across different geographical regions, have been identified. For example, genotype A has a tendency for chronicity, whereas viral mutations are frequently encountered in genotype C. Both chronicity and mutation frequency are common in genotype D. LC and progression to HCC are more commonly encountered with genotypes C and D than the other genotypes. Pathogenic differences between HBV genotypes explain disease intensity, progression to LC, and HCC. In conclusion, genotype determination in CHB infection is important in estimating disease progression and planning optimal antiviral treatment.At least 600000 individuals worldwide annually die of hepatitis B virus (HBV)-related diseases, such as chronic hepatitis B (CHB), liver cirrhosis (LC), and hepatocellular carcinoma (HCC). Many viral factors, such as viral load, genotype, and specific viral mutations, are known to affect disease progression. HBV reverse transcriptase does not have a proofreading function, therefore, many HBV genotypes, sub-genotypes, mutants, and recombinants emerge. Differences between genotypes in response to antiviral treatment have been determined. To date, 10 HBV genotypes, scattered across different geographical regions, have been identified. For example, genotype A has a tendency for chronicity, whereas viral mutations are frequently encountered in genotype C. Both chronicity and mutation frequency are common in genotype D. LC and progression to HCC are more commonly encountered with genotypes C and D than the other genotypes. Pathogenic differences between HBV genotypes explain disease intensity, progression to LC, and HCC. In conclusion, genotype determination in CHB infection is important in estimating disease progression and planning optimal antiviral treatment.
Author Sunbul, Mustafa
Author_xml – sequence: 1
  givenname: Mustafa
  surname: Sunbul
  fullname: Sunbul, Mustafa
  organization: Mustafa Sunbul, Department of Infectious Diseases, School of Medicine, Ondokuz Mayis University, 55139 Samsun, Turkey
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24833873$$D View this record in MEDLINE/PubMed
BookMark eNpNj0tLw0AYRQep2IfuXUmWbhLnlcyMOy1qhYIbXYd5fC1TkknMTCr99y1YwdU9cA8X7hxNQhcAoVuCCya4fPjZbYs9xYUnsig5FRdoRilROZUcT_7xFM1j3GFMGSvpFZpSLhmTgs3QagW9Tj75mD1nez-MMdtC6NKhh_iYbZvO6CZzPqbBmzH5LmQ6uMw2Pnh7anzbd0PSwcI1utzoJsLNORfo6_Xlc7nK1x9v78undW45xykHhgUIhc1GVaAqQwgxG0NA8ApYCdIyh03lNJZOlEbaiihuJNYVI446ZukC3f_u9kP3PUJMdeujhabRAbox1qRkileKMXxS787qaFpwdT_4Vg-H-u89PQJuh18K
CitedBy_id crossref_primary_10_3390_v11090860
crossref_primary_10_3390_ijms241310547
crossref_primary_10_12688_f1000research_128116_2
crossref_primary_10_12688_f1000research_128116_1
crossref_primary_10_3390_genes9090420
crossref_primary_10_1002_jmv_25353
crossref_primary_10_1371_journal_pone_0172101
crossref_primary_10_1093_carcin_bgx145
crossref_primary_10_1038_srep13734
crossref_primary_10_3390_microorganisms12030599
crossref_primary_10_1111_jvh_13014
crossref_primary_10_1186_s12929_018_0442_4
crossref_primary_10_1371_journal_pone_0188944
crossref_primary_10_1002_jmv_24828
crossref_primary_10_3390_microorganisms10122381
crossref_primary_10_1038_s41598_017_07642_6
crossref_primary_10_3390_v15081729
crossref_primary_10_1002_jmv_24942
crossref_primary_10_1111_liv_15249
crossref_primary_10_33549_physiolres_934979
crossref_primary_10_3748_wjg_v22_i17_4287
crossref_primary_10_1080_14656566_2022_2144219
crossref_primary_10_1016_j_humimm_2025_111293
crossref_primary_10_3390_v13020245
crossref_primary_10_1111_brv_12457
crossref_primary_10_3748_wjg_v21_i21_6684
crossref_primary_10_1128_AAC_00082_18
crossref_primary_10_3389_fmicb_2021_663534
crossref_primary_10_3389_fmicb_2022_1020147
crossref_primary_10_3390_pathogens8020063
crossref_primary_10_1016_j_virusres_2017_12_007
crossref_primary_10_1016_j_jcv_2018_04_005
crossref_primary_10_4102_ajlm_v11i1_1677
crossref_primary_10_1016_j_rdc_2018_06_006
crossref_primary_10_1371_journal_pone_0291378
crossref_primary_10_1155_2019_1475163
crossref_primary_10_1007_s00705_017_3632_6
crossref_primary_10_3138_canlivj_2023_0003
crossref_primary_10_3390_pathogens10101333
crossref_primary_10_1016_j_tim_2018_08_011
crossref_primary_10_1186_s12879_025_11226_5
crossref_primary_10_3389_fcimb_2021_590989
crossref_primary_10_1186_s12879_025_11166_0
crossref_primary_10_1097_MEG_0000000000001357
crossref_primary_10_3851_IMP3055
crossref_primary_10_3390_v14051085
crossref_primary_10_1007_s12072_016_9779_5
crossref_primary_10_3390_microorganisms9122607
crossref_primary_10_3390_diagnostics12102393
crossref_primary_10_1093_nar_gkx823
crossref_primary_10_1016_j_jiph_2023_12_020
crossref_primary_10_1016_j_jinf_2020_07_019
crossref_primary_10_1016_j_gastha_2023_10_008
crossref_primary_10_3389_fimmu_2019_01735
crossref_primary_10_3389_fimmu_2022_1034968
crossref_primary_10_1016_j_antiviral_2018_12_021
crossref_primary_10_5812_hepatmon_34420
crossref_primary_10_1016_j_jiph_2020_11_016
crossref_primary_10_1186_s12879_020_05269_z
crossref_primary_10_1186_s12889_023_15130_y
crossref_primary_10_1016_j_jcv_2018_01_011
crossref_primary_10_1053_j_gastro_2018_11_037
crossref_primary_10_3389_fgwh_2023_1184090
crossref_primary_10_3389_fimmu_2022_1032716
crossref_primary_10_1016_j_apsusc_2014_06_084
crossref_primary_10_1038_s41598_017_02012_8
crossref_primary_10_1016_j_jcv_2017_08_001
crossref_primary_10_1371_journal_pone_0265063
crossref_primary_10_1186_s12889_022_14296_1
crossref_primary_10_5812_hepatmon_34790
crossref_primary_10_3390_jcm12216807
crossref_primary_10_1016_j_vaccine_2022_03_049
crossref_primary_10_3389_fimmu_2020_02074
crossref_primary_10_3390_jcm14082618
crossref_primary_10_3390_pathogens11010020
crossref_primary_10_2478_rrlm_2020_0010
crossref_primary_10_1016_j_addr_2020_05_010
crossref_primary_10_5812_hepatmon_12472
crossref_primary_10_1093_cid_ciz1170
crossref_primary_10_1016_j_jhep_2022_01_007
crossref_primary_10_1016_j_gtc_2019_02_007
crossref_primary_10_1016_j_jhep_2017_07_011
crossref_primary_10_1002_ijc_70092
crossref_primary_10_1007_s11262_018_1610_z
crossref_primary_10_1016_S2468_1253_24_00237_1
crossref_primary_10_1111_aogs_14448
crossref_primary_10_1016_j_coviro_2018_03_006
crossref_primary_10_1016_j_vaccine_2020_09_083
crossref_primary_10_1053_j_ackd_2018_10_004
crossref_primary_10_4103_ijmr_ijmr_444_22
crossref_primary_10_1097_IPC_0000000000000990
crossref_primary_10_1016_j_mvr_2019_103970
crossref_primary_10_1016_j_ijmmb_2021_04_012
crossref_primary_10_1099_jgv_0_000789
crossref_primary_10_1111_hepr_12981
crossref_primary_10_3390_v16050724
crossref_primary_10_1089_vim_2020_0176
crossref_primary_10_1016_j_meegid_2018_06_013
crossref_primary_10_5812_hepatmon_43838
crossref_primary_10_3390_ijms222011051
crossref_primary_10_1002_anie_202403123
crossref_primary_10_1093_ve_veaa006
crossref_primary_10_1371_journal_pone_0197109
crossref_primary_10_1016_j_jmoldx_2018_03_001
crossref_primary_10_1016_j_cld_2018_06_002
crossref_primary_10_1016_j_meegid_2022_105371
crossref_primary_10_4274_jcrpe_galenos_2021_2021_8_4
crossref_primary_10_1016_j_jiph_2016_02_006
crossref_primary_10_1111_1348_0421_12947
crossref_primary_10_3389_fmicb_2022_837746
crossref_primary_10_1002_hep_30050
crossref_primary_10_1016_j_virol_2017_10_016
crossref_primary_10_1016_j_virusres_2017_09_025
crossref_primary_10_3390_vaccines12050488
crossref_primary_10_1002_ange_202403123
crossref_primary_10_33073_pjm_2019_044
crossref_primary_10_1016_j_coviro_2016_09_012
crossref_primary_10_3389_fimmu_2017_01285
crossref_primary_10_1186_s12985_015_0313_5
crossref_primary_10_1016_j_meegid_2024_105618
crossref_primary_10_1097_FPC_0000000000000187
crossref_primary_10_2147_IDR_S335666
crossref_primary_10_12688_wellcomeopenres_9952_1
crossref_primary_10_1111_ijcp_14812
crossref_primary_10_1111_jvh_13485
crossref_primary_10_1186_s12879_016_2149_z
crossref_primary_10_3390_v15122395
crossref_primary_10_1016_j_jbc_2021_100589
crossref_primary_10_1016_j_jcv_2015_09_004
crossref_primary_10_1016_j_yamp_2018_06_006
crossref_primary_10_36233_0372_9311_578
crossref_primary_10_3748_wjg_v23_i2_306
crossref_primary_10_1016_j_sjbs_2021_11_012
crossref_primary_10_1111_liv_16048
crossref_primary_10_1016_j_actatropica_2024_107318
crossref_primary_10_3390_cancers13102454
crossref_primary_10_3390_vaccines13090916
crossref_primary_10_1016_j_bjid_2022_102367
crossref_primary_10_1097_MD_0000000000020302
crossref_primary_10_1038_s41598_025_17245_1
crossref_primary_10_1515_cclm_2017_1133
crossref_primary_10_3390_ph17070964
crossref_primary_10_1016_j_jhep_2018_11_010
crossref_primary_10_1080_13557858_2022_2040957
crossref_primary_10_3390_v16060954
crossref_primary_10_1111_jvh_13099
crossref_primary_10_1155_2017_1096406
crossref_primary_10_1007_s12072_021_10162_1
crossref_primary_10_3390_ijms24054964
crossref_primary_10_1111_hepr_13768
crossref_primary_10_1186_s12879_015_1096_4
crossref_primary_10_1080_13102818_2015_1093430
crossref_primary_10_1136_gutjnl_2020_322719
crossref_primary_10_4254_wjh_v10_i11_807
crossref_primary_10_1111_jgh_12831
crossref_primary_10_1007_s11262_024_02115_1
crossref_primary_10_1016_j_jcv_2020_104527
crossref_primary_10_1016_j_meegid_2016_06_002
crossref_primary_10_3389_fimmu_2019_01319
crossref_primary_10_3390_v9080199
crossref_primary_10_1111_apm_12704
crossref_primary_10_1002_hep4_1595
crossref_primary_10_1007_s00705_018_3764_3
crossref_primary_10_1111_hepr_13194
crossref_primary_10_1111_1751_2980_13172
crossref_primary_10_3390_genes9100495
crossref_primary_10_1177_0009922816650599
crossref_primary_10_3390_microorganisms11081908
crossref_primary_10_1007_s00705_020_04686_4
crossref_primary_10_7554_eLife_26738
crossref_primary_10_1371_journal_pone_0276618
crossref_primary_10_1016_j_virusres_2018_07_014
crossref_primary_10_1186_s12879_020_05025_3
crossref_primary_10_1089_omi_2023_0171
crossref_primary_10_1177_0956462419849252
crossref_primary_10_3390_ph15121542
crossref_primary_10_1080_15321819_2022_2163178
crossref_primary_10_1016_j_coviro_2017_03_019
crossref_primary_10_1016_j_genrep_2019_100548
crossref_primary_10_1080_07391102_2020_1830852
crossref_primary_10_1038_s41594_020_0427_3
crossref_primary_10_1186_s12944_016_0400_7
crossref_primary_10_1007_s12325_016_0305_x
crossref_primary_10_1186_s12879_023_08524_1
crossref_primary_10_3389_fvets_2023_1248445
crossref_primary_10_1016_S2468_1253_18_30308_X
crossref_primary_10_3748_wjg_v24_i19_2095
crossref_primary_10_1128_spectrum_01439_25
crossref_primary_10_1128_jvi_00424_24
crossref_primary_10_3389_fmed_2022_890339
crossref_primary_10_1177_1176934319861337
crossref_primary_10_3390_v15112186
crossref_primary_10_1128_AAC_01463_20
crossref_primary_10_7759_cureus_19152
crossref_primary_10_1016_j_bjid_2024_104468
crossref_primary_10_1080_14737159_2022_2076595
crossref_primary_10_5493_wjem_v15_i2_102395
crossref_primary_10_3390_v15122302
crossref_primary_10_1093_infdis_jiw049
crossref_primary_10_1186_s11658_023_00440_1
crossref_primary_10_4103_npmj_npmj_19_22
crossref_primary_10_7705_biomedica_v36i0_2976
crossref_primary_10_3904_kjim_2016_180
crossref_primary_10_1016_j_virol_2025_110692
crossref_primary_10_3390_pathogens13010060
crossref_primary_10_1186_s12879_022_07528_7
crossref_primary_10_1111_jvh_13052
crossref_primary_10_3390_v13061167
crossref_primary_10_3748_wjg_v24_i16_1708
crossref_primary_10_3390_v15010150
crossref_primary_10_1371_journal_pone_0215011
crossref_primary_10_3389_fmicb_2023_1137084
crossref_primary_10_1038_s41598_024_77362_1
crossref_primary_10_1016_j_bjid_2015_03_007
crossref_primary_10_1038_nrdp_2018_35
crossref_primary_10_1016_j_eujim_2018_05_009
crossref_primary_10_3390_genes9090453
crossref_primary_10_1002_iid3_1182
crossref_primary_10_3390_cancers16040777
crossref_primary_10_3390_vaccines9070754
crossref_primary_10_1155_2020_7027169
crossref_primary_10_1186_s12879_020_05229_7
crossref_primary_10_1016_j_compbiomed_2025_110811
crossref_primary_10_1371_journal_pone_0237252
crossref_primary_10_1007_s00535_015_1128_2
crossref_primary_10_1016_j_omtn_2018_02_005
crossref_primary_10_1371_journal_pntd_0012262
crossref_primary_10_3390_microorganisms9081787
crossref_primary_10_1016_j_jcv_2017_12_009
crossref_primary_10_3389_fmicb_2021_687785
crossref_primary_10_3390_ijms22020479
crossref_primary_10_2147_JBM_S314556
crossref_primary_10_1016_j_clinre_2023_102180
crossref_primary_10_1186_s12879_017_2697_x
crossref_primary_10_3390_microorganisms11071739
crossref_primary_10_1186_s12985_025_02829_0
crossref_primary_10_1186_s12887_025_05569_w
crossref_primary_10_3389_fmicb_2022_946703
crossref_primary_10_1002_jmv_24368
crossref_primary_10_1002_hep_28378
crossref_primary_10_1371_journal_pone_0218744
crossref_primary_10_1097_MD_0000000000018319
crossref_primary_10_1097_MEG_0000000000001381
crossref_primary_10_1016_j_vaccine_2017_07_082
crossref_primary_10_1111_jvh_13889
crossref_primary_10_1002_cld_729
crossref_primary_10_1002_jmv_25346
crossref_primary_10_1111_jvh_13525
crossref_primary_10_1016_j_biologicals_2019_01_003
crossref_primary_10_1016_j_ijmmb_2021_01_002
crossref_primary_10_3748_wjg_v29_i11_1721
crossref_primary_10_1016_j_jbc_2022_101698
crossref_primary_10_3390_diagnostics13030368
ContentType Journal Article
DBID CGR
CUY
CVF
ECM
EIF
NPM
7X8
DOI 10.3748/wjg.v20.i18.5427
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod no_fulltext_linktorsrc
EISSN 2219-2840
ExternalDocumentID 24833873
Genre Journal Article
Review
GroupedDBID ---
123
29R
2WC
36B
53G
5VR
8WL
AAKDD
ACGFO
AENEX
AFUIB
ALMA_UNASSIGNED_HOLDINGS
CCEZO
CGR
CHBEP
CIEJG
CS3
CUY
CVF
CW9
DIK
DU5
E3Z
EBS
ECM
EIF
EJD
F5P
FRP
GX1
HYE
NPM
OK1
P2P
RNS
RPM
TR2
XSB
7X8
ID FETCH-LOGICAL-c440t-e307e790bf96e96b111bfb1e746e35e8c3d0b6da08d75b8c6194b80a631d2d3c2
IEDL.DBID 7X8
ISICitedReferencesCount 299
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000336048100027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2219-2840
IngestDate Fri Jul 11 11:29:22 EDT 2025
Mon Jul 21 06:04:04 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed false
IsScholarly true
Issue 18
Keywords Hepatitis B virus
Viral mutation
Anti-viral therapy
Chronic hepatitis B
Genotypes
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c440t-e307e790bf96e96b111bfb1e746e35e8c3d0b6da08d75b8c6194b80a631d2d3c2
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Review-3
content type line 23
OpenAccessLink https://www.wjgnet.com/1007-9327/full/v20/i18/5427.htm
PMID 24833873
PQID 1539469330
PQPubID 23479
ParticipantIDs proquest_miscellaneous_1539469330
pubmed_primary_24833873
PublicationCentury 2000
PublicationDate 2014-05-14
PublicationDateYYYYMMDD 2014-05-14
PublicationDate_xml – month: 05
  year: 2014
  text: 2014-05-14
  day: 14
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle World journal of gastroenterology : WJG
PublicationTitleAlternate World J Gastroenterol
PublicationYear 2014
References 21199523 - J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:123-30
23740667 - Int J Cancer. 2013 Dec 15;133(12):2864-71
12076712 - Hepatol Res. 2002 Jul;23(3):167-177
23305043 - Aliment Pharmacol Ther. 2013 Mar;37(5):517-26
15779048 - J Med Virol. 2005 May;76(1):33-9
10702206 - Gastroenterology. 2000 Mar;118(3):554-9
12100608 - J Gastroenterol Hepatol. 2002 Jun;17(6):643-50
23252849 - Microbiol Immunol. 2013 Feb;57(2):122-9
23336976 - Virol J. 2013;10:27
23501362 - Virus Res. 2013 Jun;174(1-2):18-26
23346148 - Hepat Mon. 2012 Nov;12(11):e6191
23183198 - Jpn J Infect Dis. 2012;65(6):476-82
15565403 - J Gastroenterol. 2004 Sep;39(9):844-50
23765773 - J Med Virol. 2013 Aug;85(8):1340-7
15800989 - World J Gastroenterol. 2005 Apr 7;11(13):1976-80
23749665 - Semin Liver Dis. 2013 May;33(2):97-102
17206751 - World J Gastroenterol. 2007 Jan 7;13(1):14-21
11257194 - J Gen Virol. 2001 Apr;82(Pt 4):883-92
23763288 - Liver Int. 2013 Oct;33(9):1363-9
23432545 - J Gastroenterol Hepatol. 2013 Jul;28(7):1234-41
12210405 - J Med Virol. 2002 Oct;68(2):175-81
22827722 - Clin Microbiol Infect. 2012 Oct;18(10):E412-8
22608364 - J Clin Virol. 2012 Aug;54(4):321-6
22473858 - Hepatology. 2013 Mar;57(3):890-6
23123214 - Virus Res. 2013 Jan;171(1):65-70
18505172 - Antivir Ther. 2008;13(2):211-20
23696925 - Int J Clin Exp Pathol. 2013;6(6):1076-85
15720535 - J Viral Hepat. 2005 Mar;12(2):192-8
22783345 - Hepat Mon. 2012 May;12(5):333-8
22016585 - Korean J Intern Med. 2011 Sep;26(3):255-61
23538336 - Infect Genet Evol. 2013 Jun;16:355-61
15578511 - Gastroenterology. 2004 Dec;127(6):1733-8
12753143 - J Gastroenterol Hepatol. 2003 Jun;18(6):630-7
23490378 - J Viral Hepat. 2013 Apr;20(4):e11-9
22579480 - Infect Genet Evol. 2012 Aug;12(6):1157-62
23304671 - Iran J Public Health. 2012;41(11):10-8
23585765 - Hepat Mon. 2013 Jan 20;13(1):e6221
16760389 - J Gen Virol. 2006 Jul;87(Pt 7):1873-82
18755887 - Gut. 2008 Dec;57(12):1713-20
22990965 - Mem Inst Oswaldo Cruz. 2012 Sep;107(6):785-9
22337297 - J Med Virol. 2012 Apr;84(4):587-95
23490376 - J Viral Hepat. 2013 Apr;20(4):e1-2
21375760 - Virol J. 2011;8:102
23383660 - J Viral Hepat. 2013 Mar;20(3):209-18
22859496 - Gut. 2013 Feb;62(2):290-8
23490386 - J Viral Hepat. 2013 Apr;20(4):e27-36
23113154 - Iran J Public Health. 2012;41(3):104-11
17063518 - J Med Virol. 2006 Dec;78(12):1688-95
16461229 - J Clin Virol. 2005 Dec;34 Suppl 1:S79-82
16831687 - J Clin Virol. 2006 May;36 Suppl 1:S12-7
23268113 - Infect Genet Evol. 2013 Mar;14:195-9
23800310 - BMC Infect Dis. 2013;13:286
18771045 - Antivir Ther. 2008;13(5):613-24
22978460 - Hepatol Res. 2013 Apr;43(4):355-64
16343058 - Liver Int. 2005 Dec;25(6):1097-107
21296172 - Mol Phylogenet Evol. 2011 Apr;59(1):114-22
22930500 - J Med Virol. 2012 Oct;84(10):1541-7
23725068 - Arch Iran Med. 2013 Jun;16(6):348-50
23424100 - J Clin Lab Anal. 2013 Mar;27(2):130-6
23071796 - PLoS One. 2012;7(10):e47372
18192693 - Carcinogenesis. 2008 Sep;29(9):1685-91
23771289 - J Infect Dev Ctries. 2013 Jun;7(6):453-67
23349904 - PLoS One. 2013;8(1):e54486
20529201 - J Viral Hepat. 2010 Sep;17(9):601-10
References_xml – reference: 23538336 - Infect Genet Evol. 2013 Jun;16:355-61
– reference: 23749665 - Semin Liver Dis. 2013 May;33(2):97-102
– reference: 12210405 - J Med Virol. 2002 Oct;68(2):175-81
– reference: 23490376 - J Viral Hepat. 2013 Apr;20(4):e1-2
– reference: 10702206 - Gastroenterology. 2000 Mar;118(3):554-9
– reference: 15800989 - World J Gastroenterol. 2005 Apr 7;11(13):1976-80
– reference: 23305043 - Aliment Pharmacol Ther. 2013 Mar;37(5):517-26
– reference: 22827722 - Clin Microbiol Infect. 2012 Oct;18(10):E412-8
– reference: 23740667 - Int J Cancer. 2013 Dec 15;133(12):2864-71
– reference: 23071796 - PLoS One. 2012;7(10):e47372
– reference: 12100608 - J Gastroenterol Hepatol. 2002 Jun;17(6):643-50
– reference: 12753143 - J Gastroenterol Hepatol. 2003 Jun;18(6):630-7
– reference: 23336976 - Virol J. 2013;10:27
– reference: 23696925 - Int J Clin Exp Pathol. 2013;6(6):1076-85
– reference: 23346148 - Hepat Mon. 2012 Nov;12(11):e6191
– reference: 23424100 - J Clin Lab Anal. 2013 Mar;27(2):130-6
– reference: 18192693 - Carcinogenesis. 2008 Sep;29(9):1685-91
– reference: 23113154 - Iran J Public Health. 2012;41(3):104-11
– reference: 23501362 - Virus Res. 2013 Jun;174(1-2):18-26
– reference: 23765773 - J Med Virol. 2013 Aug;85(8):1340-7
– reference: 22978460 - Hepatol Res. 2013 Apr;43(4):355-64
– reference: 15578511 - Gastroenterology. 2004 Dec;127(6):1733-8
– reference: 21296172 - Mol Phylogenet Evol. 2011 Apr;59(1):114-22
– reference: 17206751 - World J Gastroenterol. 2007 Jan 7;13(1):14-21
– reference: 15779048 - J Med Virol. 2005 May;76(1):33-9
– reference: 12076712 - Hepatol Res. 2002 Jul;23(3):167-177
– reference: 15720535 - J Viral Hepat. 2005 Mar;12(2):192-8
– reference: 23585765 - Hepat Mon. 2013 Jan 20;13(1):e6221
– reference: 22930500 - J Med Virol. 2012 Oct;84(10):1541-7
– reference: 18771045 - Antivir Ther. 2008;13(5):613-24
– reference: 11257194 - J Gen Virol. 2001 Apr;82(Pt 4):883-92
– reference: 18755887 - Gut. 2008 Dec;57(12):1713-20
– reference: 17063518 - J Med Virol. 2006 Dec;78(12):1688-95
– reference: 23800310 - BMC Infect Dis. 2013;13:286
– reference: 22859496 - Gut. 2013 Feb;62(2):290-8
– reference: 23183198 - Jpn J Infect Dis. 2012;65(6):476-82
– reference: 16343058 - Liver Int. 2005 Dec;25(6):1097-107
– reference: 23432545 - J Gastroenterol Hepatol. 2013 Jul;28(7):1234-41
– reference: 22337297 - J Med Virol. 2012 Apr;84(4):587-95
– reference: 21375760 - Virol J. 2011;8:102
– reference: 23383660 - J Viral Hepat. 2013 Mar;20(3):209-18
– reference: 23771289 - J Infect Dev Ctries. 2013 Jun;7(6):453-67
– reference: 22473858 - Hepatology. 2013 Mar;57(3):890-6
– reference: 23490386 - J Viral Hepat. 2013 Apr;20(4):e27-36
– reference: 23725068 - Arch Iran Med. 2013 Jun;16(6):348-50
– reference: 23252849 - Microbiol Immunol. 2013 Feb;57(2):122-9
– reference: 22990965 - Mem Inst Oswaldo Cruz. 2012 Sep;107(6):785-9
– reference: 23349904 - PLoS One. 2013;8(1):e54486
– reference: 23268113 - Infect Genet Evol. 2013 Mar;14:195-9
– reference: 16760389 - J Gen Virol. 2006 Jul;87(Pt 7):1873-82
– reference: 22579480 - Infect Genet Evol. 2012 Aug;12(6):1157-62
– reference: 16461229 - J Clin Virol. 2005 Dec;34 Suppl 1:S79-82
– reference: 23490378 - J Viral Hepat. 2013 Apr;20(4):e11-9
– reference: 22016585 - Korean J Intern Med. 2011 Sep;26(3):255-61
– reference: 16831687 - J Clin Virol. 2006 May;36 Suppl 1:S12-7
– reference: 23763288 - Liver Int. 2013 Oct;33(9):1363-9
– reference: 23123214 - Virus Res. 2013 Jan;171(1):65-70
– reference: 20529201 - J Viral Hepat. 2010 Sep;17(9):601-10
– reference: 22608364 - J Clin Virol. 2012 Aug;54(4):321-6
– reference: 21199523 - J Gastroenterol Hepatol. 2011 Jan;26 Suppl 1:123-30
– reference: 22783345 - Hepat Mon. 2012 May;12(5):333-8
– reference: 23304671 - Iran J Public Health. 2012;41(11):10-8
– reference: 18505172 - Antivir Ther. 2008;13(2):211-20
– reference: 15565403 - J Gastroenterol. 2004 Sep;39(9):844-50
SSID ssj0023352
Score 2.5868318
SecondaryResourceType review_article
Snippet At least 600000 individuals worldwide annually die of hepatitis B virus (HBV)-related diseases, such as chronic hepatitis B (CHB), liver cirrhosis (LC), and...
SourceID proquest
pubmed
SourceType Aggregation Database
Index Database
StartPage 5427
SubjectTerms Antiviral Agents - therapeutic use
Biomarkers - blood
Drug Resistance, Viral
Genotype
Global Health
Hepatitis B - diagnosis
Hepatitis B - drug therapy
Hepatitis B - epidemiology
Hepatitis B - immunology
Hepatitis B - virology
Hepatitis B e Antigens - blood
Hepatitis B Surface Antigens - blood
Hepatitis B virus - drug effects
Hepatitis B virus - genetics
Hepatitis B virus - immunology
Hepatitis B virus - pathogenicity
Humans
Phenotype
Treatment Outcome
Title Hepatitis B virus genotypes: global distribution and clinical importance
URI https://www.ncbi.nlm.nih.gov/pubmed/24833873
https://www.proquest.com/docview/1539469330
Volume 20
WOSCitedRecordID wos000336048100027&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText
inHoldings 1
isFullTextHit
isPrint
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV07T8MwELaAMrDwEK_ykpFY3dqOk9gsCBBVB6g6AOoWxY-gVCItTVv-PuckhQkJiSVbpOhyd7677_x9CF0JbjKPbxGulSTCuIykNLREhgrOS8s0r7QBXx_jwUCORmrYDNzKZq1ylROrRG0nxs_IuxCZClo5aL9vph_Eq0Z5dLWR0FhHrQBKGb_SFY--UQTu7xN5cTmISgJpmNYwpSdc6X6O3zpLTjs5k51Q8Pj3ArM6aHo7__3EXbTdlJj4tvaJPbTmin3U7zu_Oz3PS3yHl_lsUWJPz-onsOU1rmlBsPUsuo0AFk4Li1f3JnH-XtXp4CEH6KX38HzfJ42KAjFC0DlxEMUuVlRnKnIq0pDcdKaZi0XkgtBJE1iqI5tSaeNQS-PHGlrSNAqY5TYw_BBtFJPCHSPMXGQlY0ZkJhVBpKSwRjNDFc2YdpK10eXKMAl4qYce0sJNFmXyY5o2Oqqtm0xrOo2ECwl9chyc_OHtU7QFFYvw8D0TZ6iVQYy6c7RplmC_2UX1--E5GD59AUFHurM
linkProvider ProQuest
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Hepatitis+B+virus+genotypes%3A+global+distribution+and+clinical+importance&rft.jtitle=World+journal+of+gastroenterology+%3A+WJG&rft.au=Sunbul%2C+Mustafa&rft.date=2014-05-14&rft.eissn=2219-2840&rft.volume=20&rft.issue=18&rft.spage=5427&rft_id=info:doi/10.3748%2Fwjg.v20.i18.5427&rft_id=info%3Apmid%2F24833873&rft_id=info%3Apmid%2F24833873&rft.externalDocID=24833873
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2219-2840&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2219-2840&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2219-2840&client=summon